In an initial RCT in Wuhan, remdesivir use showed a nonsignificant trend toward reduced time to clinical improvement. 72 However, this trial did not reach its target enrollment because of marked reductions in new patient presentations.
1
—
—
In an initial RCT in Wuhan, remdesivir use showed a nonsignificant trend toward reduced time to clinical improvement. 72 However, this trial did not reach its target enrollment because of marked reductions in new patient presentations.